| Issue Date |
Title |
Author(s) |
| 2015 |
Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial |
Li, Huafang;Yao, Chen;Shi, Jianguo;Yang, Fude;Qi, Shuguang;Wang, Lili;Zhang, Honggeng;Li, Jie;Wang, Chuanyue;Wang, Chuansheng;Liu, Cui;Li, Lehua;Wang, Qiang;Li, Keqing;Luo, Xiaoyan;Gu, Niufan |
| 2016 |
Efficacy and safety of quetiapine extended release monotherapy in bipolar depression: a multi-center, randomized, double-blind, placebo-controlled trial |
Li, Huafang;Gu, Niufan;Zhang, Hongyan;Wang, Gang;Tan, Qingrong;Yang, Fude;Ning, Yuping;Zhang, Honggeng;Lu, Zheng;Xu, Xiufeng;Shi, Jianguo;Gao, Chengge;Li, Lingjiang;Zhang, Kerang;Tian, Hongjun;Wang, Xiaoping;Li, Keqing;Li, Huichun;Xu, Yi;Xie, Shiping;Yu, Xin |
| 2010 |
INTRAMUSCULAR ZIPRASIDONE HAS IMPROVED TOLERABILITY OVER HALOPERIDOL AND COMPARABLE EFFICACY FOR CONTROL OF AGITATION IN SCHIZOPHRENIA IN CHINESE PATIENTS |
Shu, Liang;Zhang, Hongyan;Wang, Gang;Zhao, Jingping;Xie, Shiping;Xu, Xiufeng;Shi, Jianguo;Deng, Hehuang;Li, Keqing;Gao, Chengge;Wang, Xiaoping;Karayal, Onur;Vanderburg, Douglas;Pan, Sharon;Tang, Haiyun |
| 2013 |
Intramuscular Ziprasidone Versus Haloperidol for Managing Agitation in Chinese Patients With Schizophrenia |
Zhang, Hongyan;Wang, Gang;Zhao, Jingping;Xie, Shiping;Xu, Xiufeng;Shi, Jianguo;Deng, Hehuang;Li, Keqing;Gao, Chengge;Wang, Xiaoping;Vanderburg, Douglas;Pan, Sharon;Tang, Haiyun;Shu, Liang;Karayal, Onur N. |
| 2015 |
The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China |
Shi, Chuan;Kang, Lan;Yao, Shuqiao;Ma, Yibin;Li, Tao;Liang, Ying;Cheng, Zhang;Xu, Yifeng;Shi, Jianguo;Xu, Xiufeng;Zhang, Congpei;Franklin, Donald R.;Heaton, Robert K.;Jin, Hua;Yu, Xin |
| Jan-2020 |
Randomized, double-blind, 6-week non-inferiority study of lurasidone and risperidone for the treatment of schizophrenia |
Feng, Yuan;Shi, Jianguo;Wang, Lili;Zhang, Xia;Tan, Yunlong;Zhao, Jingyuan;Ning, Yuping;Xie, Shiping;Liu, Xuejun;Liu, Qi;Li, Keqing;Wang, Xiaoliang;Li, Lehua;Xu, Xiufeng;Deng, Wei;Luo, Xiaoyan;Wang, Gang |
| 2016 |
Safety and efficacy of paliperidone extendedrelease in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study |
Zhang, Hongyan;Li, Huafang;Liu, Yanning;Wu, Cathy;Wu, Qingqi;Nuamah, Isaac;Shi, Jianguo;Xie, Shiping;Wang, Gang;Gopal, Srihari |
| 2019 |
What is the optimal neuropsychological test battery for schizophrenia in China? |
Shi, Chuan;Kang, Lan;Yao, Shuqiao;Ma, Yibin;Li, Tao;Liang, Ying;Cheng, Zhang;Xu, Yifeng;Shi, Jianguo;Xu, Xiufeng;Zhang, Congpei;Franklin, Donald R.;Heaton, Robert K.;Jin, Hua;Yu, Xin |
